Pre & Post Muscular Fatigue

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Clinical Trial Summary

Many studies have related the presence of dynamic valgus with several musculoskeletal injuries of the hip, knee and ankle. The weakness of the hip abductors is cited as one of the factors linked to this poor dynamic alignment of the lower limb, however, motor control can also be one of the factors responsible for the poor alignment of the lower limbs.

See also
Status	Clinical Trial	Phase
Recruiting	`NCT05256420` - Effect of Kinesiotape on Postural Control in Non-operated Anterior Cruciate Ligament Subjects	N/A
Recruiting	`NCT04616508` - Online Motor Control in People With Parkinson's Disease	N/A
Completed	`NCT03655327` - Reach to Grasp Movement of Stroke Patients: Different Heights and Weights

NCT number	NCT05332600
Study type	Interventional
Source	Faculdade de Ciências Médicas da Santa Casa de São Paulo
Contact
Status	Completed
Phase	N/A
Start date	May 1, 2022
Completion date	May 30, 2023

Pre and Post Muscular Fatigue - DROP-JUMP TEST

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms